In the 90 days previous to the date of this filing, there have been 2 insider transactions reported to the SEC for Alexion Pharmaceuticals. These transactions came from the activities of 2 individual insiders that resulted in a net acquisition of 3,336 company shares. This compares with the preceding 90-day window of time where there were 7 transactions from 6 insiders which resulted in the net disposition of 18,704 shares.
This level of insider transactions is below that of the peer group average in the 55-company Biopharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 32.4 transactions per company, with company insiders acquiring on average 102,907 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/899866/000089986619000105/xslF345X03/wf-form4_157550355623759.xml
|Insider Trends: Pacific Premier Bancorp Insider Conv...|
|Insider Trends: 90-Day Insider Selling Trend Prolong...|
|Insider Trends: Insider Sale Reduces 90-Day Buy Tren...|
|Insider Trends: Insider Sale Eases Back 90-Day Buy T...|
|Insider Trends: Insider Purchase of Zymeworks Stock ...|